From d47dd2a0334073e761682a445e3d83069558f080 Mon Sep 17 00:00:00 2001 From: ninavangoethem <49899773+ninavangoethem@users.noreply.github.com> Date: Fri, 2 Aug 2024 16:52:25 +0200 Subject: [PATCH] Update prototyping-research-questions.md (#334) Added the analysis results as they now have been published --- showcase/prototyping-research-questions.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/showcase/prototyping-research-questions.md b/showcase/prototyping-research-questions.md index 75288a1a..5f1f62ed 100644 --- a/showcase/prototyping-research-questions.md +++ b/showcase/prototyping-research-questions.md @@ -109,7 +109,7 @@ An analytical pipeline was developed and tested with the support of the syntheti A detailed description of the security measures that will be implemented to prevent unauthorised access to personal data within the secured processing environments (SPEs) of each of the Participating Nodes, as well as a description of the anonymisation/pseudonymisation techniques that will be implemented, is provided in the published [Data Management Plan (DMP)](https://zenodo.org/doi/10.5281/zenodo.7625783). -The [preliminary outputs](https://zenodo.org/doi/10.5281/zenodo.7871533), i.e., interactive reports of each main step of the analytical pipeline, have been published for Aragon, Spain. +The [local outputs produced by each Participant Node and the comparative analysis](https://zenodo.org/doi/10.5281/zenodo.12731611), i.e., interactive reports of each main step of the analytical pipeline within each site as well as the SARS-CoV-2 vaccine effectiveness comparative analysis results across sites, have been published.